These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9247167)
1. Combination of antitumor ether lipid with lipids of complementary molecular shape reduces its hemolytic activity. Perkins WR; Dause RB; Li X; Franklin JC; Cabral-Lilly DJ; Zha Y; Dank EH; Mayhew E; Janoff AS Biochim Biophys Acta; 1997 Jul; 1327(1):61-8. PubMed ID: 9247167 [TBL] [Abstract][Full Text] [Related]
2. Stability of association of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine with liposomes is composition dependent. Mayhew E; Ahmad I; Bhatia S; Dause R; Filep J; Janoff AS; Kaisheva E; Perkins WR; Zha Y; Franklin JC Biochim Biophys Acta; 1997 Oct; 1329(1):139-48. PubMed ID: 9370251 [TBL] [Abstract][Full Text] [Related]
3. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine. Ahmad I; Filep JJ; Franklin JC; Janoff AS; Masters GR; Pattassery J; Peters A; Schupsky JJ; Zha Y; Mayhew E Cancer Res; 1997 May; 57(10):1915-21. PubMed ID: 9157985 [TBL] [Abstract][Full Text] [Related]
4. ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor. Mollinedo F; Gajate C; Martín-Santamaría S; Gago F Curr Med Chem; 2004 Dec; 11(24):3163-84. PubMed ID: 15579006 [TBL] [Abstract][Full Text] [Related]
5. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220 [TBL] [Abstract][Full Text] [Related]
6. Modulation of polymorphic properties of dielaidoylphosphatidylethanolamine by the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine. Sánchez-Piñera P; Aranda FJ; Micol V; de Godos A; Gómez-Fernández JC Biochim Biophys Acta; 1999 Mar; 1417(2):202-10. PubMed ID: 10082796 [TBL] [Abstract][Full Text] [Related]
7. Effects of the anti-neoplastic agent ET-18-OCH3 and some analogs on the biophysical properties of model membranes. Torrecillas A; Aroca-Aguilar JD; Aranda FJ; Gajate C; Mollinedo F; Corbalán-García S; de Godos A; Gómez-Fernández JC Int J Pharm; 2006 Aug; 318(1-2):28-40. PubMed ID: 16624506 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues. Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of the effect of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine and some homologous compounds on PKC alpha and PKC epsilon. Conesa-Zamora P; Mollinedo F; Corbalán-García S; Gómez-Fernández JC Biochim Biophys Acta; 2005 Feb; 1687(1-3):110-9. PubMed ID: 15708359 [TBL] [Abstract][Full Text] [Related]
10. Correlation between the effect of the anti-neoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine on the membrane and the activity of protein kinase Calpha. Aroca JD; Sánchez-Piñera P; Corbalán-García S; Conesa-Zamora P; de Godos A; Gómez-Fernández JC Eur J Biochem; 2001 Dec; 268(24):6369-78. PubMed ID: 11737191 [TBL] [Abstract][Full Text] [Related]
11. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Chabot MC; Wykle RL; Modest EJ; Daniel LW Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230 [TBL] [Abstract][Full Text] [Related]
13. The ether lipid ET-18-OCH3 increases cytosolic Ca2+ concentrations in Madin Darby canine kidney cells. Jan CR; Wu SN; Tseng CJ Br J Pharmacol; 1999 Jul; 127(6):1502-10. PubMed ID: 10455302 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981 [TBL] [Abstract][Full Text] [Related]
15. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines. Civoli F; Daniel LW Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778 [TBL] [Abstract][Full Text] [Related]
16. Growth inhibitory effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine. Peters AC; Ahmad I; Janoff AS; Pushkareva MY; Mayhew E Lipids; 1997 Oct; 32(10):1045-54. PubMed ID: 9358430 [TBL] [Abstract][Full Text] [Related]
17. The conformational properties of the antineoplastic ether lipid 1-thiohexadecyl-2-O-methyl-S-glycero-3-phosphocholine. Mavromoustakos T; Theodoropoulou E; Yang DP; Lin SY; Koufaki M; Makriyannis A Chem Phys Lipids; 1996 Nov; 84(1):21-34. PubMed ID: 8952050 [TBL] [Abstract][Full Text] [Related]
18. Edelfosine is incorporated into rafts and alters their organization. Ausili A; Torrecillas A; Aranda FJ; Mollinedo F; Gajate C; Corbalán-García S; de Godos A; Gómez-Fernández JC J Phys Chem B; 2008 Sep; 112(37):11643-54. PubMed ID: 18712919 [TBL] [Abstract][Full Text] [Related]
19. Surface-active properties of the antitumour ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (edelfosine). Busto JV; Sot J; Goñi FM; Mollinedo F; Alonso A Biochim Biophys Acta; 2007 Jul; 1768(7):1855-60. PubMed ID: 17543274 [TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine. Boggs KP; Rock CO; Jackowski S J Biol Chem; 1995 May; 270(19):11612-8. PubMed ID: 7744800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]